CN116948865A - Bacillus coagulans and application thereof - Google Patents
Bacillus coagulans and application thereof Download PDFInfo
- Publication number
- CN116948865A CN116948865A CN202310473617.4A CN202310473617A CN116948865A CN 116948865 A CN116948865 A CN 116948865A CN 202310473617 A CN202310473617 A CN 202310473617A CN 116948865 A CN116948865 A CN 116948865A
- Authority
- CN
- China
- Prior art keywords
- bacillus coagulans
- application
- rice
- fermented
- vermicelli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000193749 Bacillus coagulans Species 0.000 title claims abstract description 74
- 229940054340 bacillus coagulans Drugs 0.000 title claims abstract description 74
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 71
- 235000009566 rice Nutrition 0.000 claims abstract description 71
- 235000019225 fermented tea Nutrition 0.000 claims abstract description 25
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 3
- 241000209094 Oryza Species 0.000 claims abstract 7
- 235000012149 noodles Nutrition 0.000 claims description 13
- 238000004321 preservation Methods 0.000 claims 1
- 238000010025 steaming Methods 0.000 abstract description 12
- 239000000796 flavoring agent Substances 0.000 abstract description 9
- 235000019634 flavors Nutrition 0.000 abstract description 9
- 239000002253 acid Substances 0.000 abstract description 7
- 235000019658 bitter taste Nutrition 0.000 abstract description 6
- 238000010411 cooking Methods 0.000 abstract description 6
- 239000003242 anti bacterial agent Substances 0.000 abstract description 5
- 229940088710 antibiotic agent Drugs 0.000 abstract description 5
- 235000019606 astringent taste Nutrition 0.000 abstract description 2
- 229940099352 cholate Drugs 0.000 abstract description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 description 67
- 235000013312 flour Nutrition 0.000 description 24
- 235000013616 tea Nutrition 0.000 description 13
- 241001122767 Theaceae Species 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000001953 sensory effect Effects 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000036541 health Effects 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 239000003833 bile salt Substances 0.000 description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000008442 polyphenolic compounds Chemical class 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002470 solid-phase micro-extraction Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- ICKWICRCANNIBI-UHFFFAOYSA-N 2,4-di-tert-butylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(C(C)(C)C)=C1 ICKWICRCANNIBI-UHFFFAOYSA-N 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- 229920000856 Amylose Polymers 0.000 description 2
- 108010001478 Bacitracin Proteins 0.000 description 2
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N D-Arabitol Natural products OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- -1 D-fucose (D-fucose) - Sorbitol Chemical compound 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 2
- DKXNBNKWCZZMJT-UHFFFAOYSA-N O4-alpha-D-Mannopyranosyl-D-mannose Natural products O=CC(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O DKXNBNKWCZZMJT-UHFFFAOYSA-N 0.000 description 2
- 108010040201 Polymyxins Proteins 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 229960003071 bacitracin Drugs 0.000 description 2
- 229930184125 bacitracin Natural products 0.000 description 2
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 description 2
- MGWAVDBGNNKXQV-UHFFFAOYSA-N diisobutyl phthalate Chemical compound CC(C)COC(=O)C1=CC=CC=C1C(=O)OCC(C)C MGWAVDBGNNKXQV-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229940093496 esculin Drugs 0.000 description 2
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229960002413 ferric citrate Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- DLRVVLDZNNYCBX-ABXHMFFYSA-N melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-ABXHMFFYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- KQJSQWZMSAGSHN-UHFFFAOYSA-N (9beta,13alpha,14beta,20alpha)-3-hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(O)=C2C KQJSQWZMSAGSHN-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- GNWUOVJNSFPWDD-XMZRARIVSA-M Cefoxitin sodium Chemical compound [Na+].N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)CC1=CC=CS1 GNWUOVJNSFPWDD-XMZRARIVSA-M 0.000 description 1
- AQKDBFWJOPNOKZ-UHFFFAOYSA-N Celastrol Natural products CC12CCC3(C)C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C2=CC=C2C1=CC(=O)C(=O)C2C AQKDBFWJOPNOKZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UHFFFAOYSA-N D-Cellobiose Natural products OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000626621 Geobacillus Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- HEBKCHPVOIAQTA-IMJSIDKUSA-N L-arabinitol Chemical compound OC[C@H](O)C(O)[C@@H](O)CO HEBKCHPVOIAQTA-IMJSIDKUSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- HAUHVTUBJKXLLM-SZPZTJOGSA-N OC[C@H](O)[C@H](O)[C@@H](O)C=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1CO Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)C=O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1CO HAUHVTUBJKXLLM-SZPZTJOGSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-WISUUJSJSA-N aldehydo-L-xylose Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WISUUJSJSA-N 0.000 description 1
- 229930195726 aldehydo-L-xylose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 229960002682 cefoxitin Drugs 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- HNZUNIKWNYHEJJ-FMIVXFBMSA-N geranyl acetone Chemical compound CC(C)=CCC\C(C)=C\CCC(C)=O HNZUNIKWNYHEJJ-FMIVXFBMSA-N 0.000 description 1
- HNZUNIKWNYHEJJ-UHFFFAOYSA-N geranyl acetone Natural products CC(C)=CCCC(C)=CCCC(C)=O HNZUNIKWNYHEJJ-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000001785 headspace extraction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 description 1
- 235000020195 rice milk Nutrition 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The application discloses a bacillus coagulans, which is classified and named as bacillus coagulansBacillus coagulans) PR06, which has been deposited at the China center for type culture Collection, under the accession number: cctccc NO: m20211589. The bacillus coagulans PR06 provided by the application has stronger acid resistance and cholate resistance, and has no resistance to most antibiotics. The application also discloses application of the bacillus coagulans in preparation of fermented rice vermicelli or fermented rice vermicelli products. The fermented tea rice vermicelli prepared by the bacillus coagulans PR06 provided by the application has no bitter and astringent taste, and is excellent in steaming and cooking and organoleptic quality and pleasant in flavor. Therefore, the bacillus coagulans PR06 provided by the applicationHas higher social application value.
Description
Technical Field
The application relates to the technical field of microbial strains and application thereof, in particular to bacillus coagulans and application thereof.
Background
Bacillus coagulans (Bacillus coagulans) is a genus of the genus Geobacillus, the cell body is rod-shaped, the spore end grows, and no flagella exists, and is a facultative anaerobic gram positive bacterium. The bacillus coagulans can grow in aerobic and anaerobic environments, can adapt to low-oxygen intestinal environments, has higher tolerance to acid and bile, can perform lactic acid fermentation, can reduce the pH value of intestinal tracts, inhibit harmful bacteria, and can promote the growth and propagation of beneficial bacteria such as bifidobacteria. Bacillus coagulans is capable of sporulation and is beneficial for restoring microecological balance of the gastrointestinal tract as compared to other lactic acid-free bacilli. The bacillus coagulans spores can germinate in a human body for about 4-6 hours, wherein 85% of the thalli can smoothly pass through a digestive system and finally germinate and propagate in intestinal tracts. Compared with the intrinsic important lactobacillus and bifidobacterium in the gastrointestinal tract, the bacillus coagulans not only has the dual effects of the lactobacillus and the bifidobacterium, but also has the unique advantages of high temperature resistance, easy culture, stable storage and the like of the bacillus. Research shows that bacillus coagulans can improve the immunity of organisms, strengthen the disease resistance and promote the digestion and metabolism of the organisms and the absorption of nutrient substances. At present, bacillus coagulans has been listed by the department of agriculture in China as a novel feed additive which can be directly fed for livestock and poultry production. Bacillus coagulans is one of the approved species in China for use in common foods, and is announced by the national health and family planning Commission of the people's republic of China, 2014, no. 6. In the field of foods, bacillus coagulans is mainly applied to probiotics soft sweets and normal-temperature acidic drinks, and no report on application of bacillus coagulans to fermented tea rice vermicelli is currently seen in the industry.
Rice flour is a staple food common in southern areas of China, has hundreds of millions of eating population, and is a rice product with the largest market specification. In 2019, annual output values of Changde rice flour and Guilin rice flour in China respectively exceed 20 hundred million and 25 hundred million yuan. The rice flour can be classified into fermented rice flour and non-fermented rice flour, and researches show that the fermented rice flour has great improvement on taste and flavor, and has better steaming and boiling characteristics and rehydration. Because the common rice flour has single nutrient components (about 75% of starch and about 7% of protein), the common rice flour lacks health-care functional components. With the enhancement of health care consciousness of people in recent years, common rice flour can not meet the requirements of people on nutrition and health care. Tea is known as 'national drink' in China, and the health care effect of the tea is accepted by the masses, wherein the health care components mainly comprise tea polyphenol, theanine and the like. The tea food meets the expectations and the requirements of consumers on health care, and the application of the tea to various foods to be processed into foods with the characteristics of the tea and the health care effect is more and more popular among consumers. Because the starch in the rice flour is relatively easy to be digested and absorbed by human body, the blood sugar level of the human body is easy to be raised after eating, and the rice flour is not suitable for diabetics. Research shows that polyphenol substance can complex with starch macromolecules to change the crystal form of starch molecules, further influence the aging behavior and digestion property of starch gel, and play a role in resisting digestion. Therefore, tea powder containing polyphenol substances is added in the rice flour processing process, so that the effect of delaying digestion of rice flour can be achieved, and the rice flour is suitable for patients with hyperglycemia to eat. However, the rice flour may have a bitter taste due to tea polyphenols and caffeine in the tea leaves.
In order to solve the problems, the inventor aims at screening out strains for preparing the fermented tea rice vermicelli or rice noodles without bitter taste, and providing a new bacterial source for development and production of the fermented tea rice vermicelli or rice noodle products.
Disclosure of Invention
The application aims to provide bacillus coagulans and application thereof, and develops a strain which can be used for preparing fermented tea rice vermicelli (strip) without bitter taste.
The application aims at realizing the following technical scheme:
bacillus coagulans, designated Bacillus coagulans (Bacillus coagulans) PR06, deposited on the China center for type culture Collection, accession number: cctccc NO: m20211589, accession number address: eight 299 channels of Wuchang district of Wuhan, hubei province, china center for type culture Collection, post code: 430072.
the bacillus coagulans PR06 provided by the application is separated from human excrement and has the colony characteristics that: after being cultured on an MRS flat plate culture medium for 24-48 hours, the bacterial colony is in a milky white, round, smooth in surface, moist and glossy shape; the scanning electron microscope observation shows that the bacterial cells are rod-shaped, and the size is 0.2-0.4x2.0-5.0 mu m; the optimum growth temperature is 50 ℃.
The application also provides application of the bacillus coagulans PR06 in processing and producing common fermented rice vermicelli or common fermented rice noodles.
The application also provides application of the bacillus coagulans PR06 in processing and producing fermented tea rice vermicelli or fermented tea rice noodles.
The application has the remarkable advantages that:
the bacillus coagulans PR06 provided by the application has stronger acid resistance and cholate resistance, and has no resistance to most antibiotics. The common fermented rice vermicelli prepared by the bacillus coagulans PR06 provided by the application has the advantages of excellent organoleptic quality, unique flavor and pleasure. The fermented tea rice vermicelli prepared by the bacillus coagulans PR06 provided by the application has no bitter and astringent taste, and is excellent in steaming and cooking and organoleptic quality and pleasant in flavor. Therefore, the bacillus coagulans PR06 provided by the application has higher social application value.
Drawings
Fig. 1 is a colony morphology of bacillus coagulans PR06.
Fig. 2 is a scanning electron microscope image of bacillus coagulans PR06.
Fig. 3 is a graph showing the growth of bacillus coagulans PR06 at different temperatures.
Fig. 4 is a diagram of a finished product of the bacillus coagulans PR06 fermented tea leaf and rice flour noodles (before cooking).
Fig. 5 is a diagram of a finished product of the bacillus coagulans PR06 fermented tea leaf and rice flour noodles (after cooking).
Detailed Description
The following examples facilitate a better understanding of the present application, but are not intended to limit the same. The experimental methods in the following examples are conventional media and experimental conditions unless otherwise specified. The test materials, reagents and the like used in the examples are all commercially available unless otherwise specified.
EXAMPLE 1 isolation and characterization of Bacillus coagulans (Bacillus coagulans) PR06
1. Isolation of strains
Taking 1.0g of fresh human excrement sample, placing the sample into a sterile centrifuge tube filled with 9.0mL of sterile water, shaking and uniformly mixing, placing the obtained bacterial suspension into boiling water at 80 ℃ for water bath for 30min, and taking out; sequentially diluting with 10-fold gradient dilution method, selecting 100 μL of diluent with proper concentration gradient, adding MRS agar (tryptone 10.0g/L, beef powder 5.0g/L, yeast powder 4.0g/L, glucose 20.0g/L, tween 80 1.0mL/L, K) 2 HPO 4 ·3H 2 O1.5 g/L, anhydrous sodium acetate 3.0g/L, ammonium citrate 2.0g/L, mgSO 4 ·7H 2 O 0.2g/L、MnSO 4 ·H 2 O0.04 g/L, agar powder 20.0g/L, distilled water 1L and pH value of 6.2-6.4), uniformly coating by using a sterile coating rod, taking sterile water as a blank control, and placing the coated sterile water in a constant temperature incubator at 45 ℃ for inversion culture for 48-72 h. The white or off-white, glossy, round, clean-edged, single-colony strain was picked, and repeatedly streaked, purified and cultured on MRS agar plate medium until a single colony was obtained, and the single-colony strain was designated PR06.
2. Identification of strains
(1) Morphology observation of colonies and thalli: strain PR06 was streaked on MRS agar plate medium and incubated at 37 ℃ for 24-48 hours, and the colony morphology (fig. 1) showed milky white, round, smooth surface, moist and glossy. The bacterial cells are in the shape of rod and the size is 0.2-0.4 μm×2.0-5.0 μm when observed under a scanning electron microscope, and the scanning electron microscope diagram is shown in FIG. 2.
(2) Growth characteristics observation of strain PR 06: the strain PR06 bacterial suspension is respectively inoculated into MRS liquid culture medium according to the inoculum size of 3.0 percent of the volume ratio, and is cultured for 24 hours at different temperatures, and the strain grows well in the environment of 30-60 ℃, and the optimal growth temperature is 50 ℃ (see figure 3).
(3) Molecular biological identification of strain PR 06: the whole genome of the strain PR06 is extracted by using a bacterial whole genome rapid extraction kit, and PCR is performed by selecting bacterial 16S rDNA universal primers 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1492R (5'-TACGGCTACCTTGTTACGACTT-3') and then sequencing and analyzing. The sequencing result is compared by BLAST, the strain is identified as bacillus coagulans, the gene sequence is shown in SEQ ID NO.1, and the sequence is named as: bacillus coagulans (Bacillus coagulans) PR06 deposited at the China center for type culture Collection, 12:10, 2021, accession number: cctccc NO: m20211589. Deposit unit address: eight 299 channels of Wuchang district of Wuhan, hubei province, china center for type culture Collection, post code: 430072.
example 2 availability of bacillus coagulans (Bacillus coagulans) PR06 to saccharides API50CHL kit (Biomerieux, france) the strain PR06 isolated in example 1 was tested for availability to saccharides and the results (table 1) show: bacillus coagulans (Bacillus coagulans) PR06 of the present application can utilize ribose, D-galactose, D-glucose, D-fructose, D-mannose, mannitol, sorbitol, N-acetylglucosamine, esculin ferric citrate, D-maltose, D-lactose, D-melibiose, D-sucrose, trehalose, D-raffinose and starch.
Table 1 results of testing the availability of sugars by strain PR06 using API50CHL kit
Substrate composition | 48h reaction results | Substrate composition | 48h reaction results |
Control | - | Esculin ferric citrate | + |
Glycerol | - | Salicin (Liu Chun) | - |
Erythritol | - | D-cellobiose | - |
D-arabinose | - | D-maltose | + |
L-arabinose | - | D-lactose | + |
Ribose | + | D-melibiose | + |
D-xylose | - | D-sucrose | + |
L-xylose | - | Trehalose | + |
Adonitol | - | Inulin (inulin) | - |
beta-methyl-D-xylosides | - | D-melezitose | - |
D-galactose | + | D-raffinose | + |
D-glucose | + | Starch | + |
D-fructose | + | Glycogen | - |
D-mannose | + | Xylitol | - |
L-sorbose | - | D-gentiobiose (in Niu Ertang) | - |
L-rhamnose | - | D-turbinase (D-melezitose) | - |
Celastrol | - | D-lyxose | - |
Inositol (inositol) | - | D-tagatose | - |
Mannitol (mannitol) | + | D-fucose (D-fucose) | - |
Sorbitol | + | L-fucose | - |
alpha-methyl-D-mannopyranoside | - | D-arabitol (D-arabitol) | - |
alpha-methyl-D-glucopyranoside | - | L-arabitol (L-arabitol) | - |
N-acetylglucosamine | + | Potassium gluconate (salt) | - |
Amygdalin | - | 2 Keto-gluconic acid potassium salt | - |
ARBULIN (arbutin) | - | 5 Keto-gluconic acid potassium salt | - |
Remarks: + represents a positive result, indicating that the strain is able to utilize the test substrate; -a negative result indicating that the strain is unable to utilize the test substrate.
EXAMPLE 3 acid and bile salt resistance of Bacillus coagulans (Bacillus coagulans) PR06
Preparing activated strain PR06 into suspension, and collecting 1.0mL of the bacterial suspension (concentration is 2.0X10) 7 cfu/mL) was inoculated into 9.0mL of MRS liquid medium having pH of 2.5, 3.0, 3.5 or bile salt concentration of 1.0, 2.0, 3.0 and 4.0g/L, respectively, cultured at 45℃for 4 hours, viable count was measured by plate count method at 0 hours after the culture and 4 hours after the culture, respectively, and survival rate (%) was calculated.
Survival rate (%) = (number of viable bacteria for 4 h/number of viable bacteria for 0 h) ×100.
TABLE 2 acid and bile salt resistance of Bacillus coagulans PR06
The results in Table 2 show that Bacillus coagulans PR06 has higher survival rate under the environments of pH of 3.0, 3.5 or bile salt concentration of 1.0, 2.0, 3.0 and 4.0g/L, which indicates that the strain has stronger acid resistance and bile salt resistance and can smoothly pass through the gastrointestinal tract to enter the large intestine of the organism to play a probiotic role.
EXAMPLE 4 antibiotic resistance of Bacillus coagulans (Bacillus coagulans) PR06 broth was inoculated into MRS broth, cultured in a 45℃biochemical incubator for 24 hours, 100. Mu.L broth was spread on MRS agar plates, and tablets containing erythromycin, penicillin, gentamicin, kanamycin, streptomycin, bacitracin, chloramphenicol, vancomycin, tetracycline, ampicillin, cefoxitin, rifampin, neomycin, nalidixic acid, ciprofloxacin, polymyxin were placed thereon, and cultured upside down in a 45℃biochemical incubator for 24 hours, and the size of the inhibition zone was observed and recorded. The experimental results are shown in table 3.
TABLE 3 bacteriostatic Effect of antibiotics on Bacillus coagulans PR06
The results in Table 3 show that Bacillus coagulans PR06 was only resistant to both bacitracin and polymyxin, but not to most other antibiotics, indicating that PR06 had good safety for use.
Example 5 preparation and sensory evaluation of Bacillus coagulans PR06 ordinary fermented rice vermicelli the early long-grained nonglutinous rice with an amylose content of more than 20% and aged for 1 to 1.5 years was milled and sieved through a 80-mesh sieve to obtain rice flour, 800g of the rice flour sample was taken, 150g of corn starch and 50g of potato starch were added, and after thoroughly mixing, the mixture was spread under an ultraviolet lamp and sterilized for 24 hours, and a proper amount of pure water was added to make the moisture content of the rice slurry 55 to 60%. Inoculating activated Bacillus coagulans PR06 (concentration: 2.0X10) on ultra-clean bench 7 cfu/mL, inoculum size 2% v/v), fermenting at 30-50deg.C for 8-18 h, and fermentingPouring the fermented rice pulp into a self-cooked silk-extrusion molding rice flour machine, steaming the obtained vermicelli for 2-10 min, cooling, aging for 3-10 h at 4-8 ℃, and finally drying until the water content is lower than 14%, thus obtaining the finished product. Sensory evaluation of the finished vermicelli shows that the bacillus coagulans PR06 common fermented rice vermicelli has good sensory quality and pleasant sweet and sour feeling when chewed.
Example 6 preparation of Bacillus coagulans PR06 fermentation type tea Rice vermicelli
Grinding long-shaped rice which has the amylose content of more than 20% and is aged for 1-1.5 years, sieving the long-shaped rice with a 80-mesh sieve to obtain rice flour, taking 800g of rice flour sample, adding 150g of corn starch and 50g of potato starch, fully and uniformly mixing, spreading the mixture under an ultraviolet lamp for sterilization for 24 hours, adding a proper amount of tea water (taking 50g of rock tea powder, adding 1L of distilled water, sterilizing for 15 minutes at 121 ℃, centrifuging, taking supernatant) and enabling the moisture content of rice pulp to be 55% -60%. Inoculating activated Bacillus coagulans PR06 (concentration: 2.0X10) on ultra-clean bench 7 cfu/mL, inoculum size 2% v/v), fermenting at 30-50 ℃ for 8-18 h, pouring the fermented rice milk into a self-cooked silk extrusion molding rice flour machine, steaming the obtained vermicelli for 2-10 min, cooling, aging at 4-8 ℃ for 3-10 h, and finally drying until the water content is lower than 14%, thus obtaining the finished product. Fig. 4 and 5 show the state diagrams before and after steaming of the bacillus coagulans PR06 fermented tea-leaf rice noodles.
Example 7 detection of steaming quality of tea leaf rice vermicelli fermented by bacillus coagulans PR06 the steaming quality of the rice vermicelli sample in example 6 was detected, specifically the breakage rate, steaming loss rate and rehydration time of the rice vermicelli were determined with reference to the standard (SN/T0395-2018), and the rehydration rate of the rice vermicelli was determined with reference to the standard (QB/T2652-2004). The measurement results are shown in Table 4.
TABLE 4 measurement of cooking quality of Bacillus coagulans PR06 fermented tea Rice vermicelli
Sample of | The breakage rate is% | Cooking loss rate% | Rehydration percentage% | Rehydration time s |
Example 6 fermented tea Rice vermicelli | 3.7±0.3 | 4.3±0.1 | 203.6±3.3 | 223±7 |
Control without PR06 inoculation | 6.1±0.5 | 5.0±0.1 | 235.6±8.2 | 202±6 |
The results in Table 4 show that the fermented tea rice noodles prepared by using the bacillus coagulans PR06 of the application have good steaming quality, the breakage rate and the steaming loss rate are both lower than 5.0%, the rehydration rate is higher than 200%, and the rehydration time is within 4 minutes (240 s).
Example 8 detection of sensory quality of Bacillus coagulans PR06 fermented tea Rice vermicelli
The sensory quality of the rice vermicelli in example 6 was evaluated, and the results are shown in table 5.
TABLE 5 sensory evaluation criteria and results for Bacillus coagulans PR06 fermented tea and rice vermicelli
The results in Table 5 show that the fermented tea rice noodles prepared by using the Bacillus coagulans PR06 of the present application are excellent in sensory quality, and the total sensory score reaches 92 minutes.
Example 9 detection of flavour substances in Bacillus coagulans PR06 fermented tea Rice vermicelli
The flavor substances in the fermented tea rice noodle sample in example 6 were detected.
The detection method comprises the following steps: a2 g sample was removed into a 15mL extraction flask and then quickly sealed. The SPME extracted fiber heads were aged at 250deg.C to no impurity peaks at the GC-MS sample inlet. Placing the sample bottle on a solid-phase microextraction device, and setting the temperature to be 85 ℃; placing the sample bottle in an extraction device, and fully heating in water bath for 5min; inserting the SPME extraction head into the head space of the sample through the bottle cap, pushing out the fiber head, wherein the extraction head is about 1.0cm higher than the upper surface of the sample, and performing head space extraction for 45min; the fiber head is withdrawn, and the extraction head is pulled out of the sample bottle; and then the extraction head is inserted into a GC-MS sample inlet, the fiber head is pushed out, analysis is carried out for 5min at 250 ℃, and sample injection analysis is carried out. The GC detection conditions were as follows: chromatographic column: HP-5MS column (30 m.times.0.25 mm,0.25 μm); carrier gas: helium gas; the flow rate is 1mL/min; the sample injection temperature was maintained at 250 ℃; the gas chromatograph oven temperature was maintained at 40 ℃ for 3min, then increased to 150 ℃ at 4 ℃/min, then to 250 ℃ at 10 ℃/min, and then kept unchanged. The MS conditions were as follows: EI ion source, electron energy 70eV, mass range 35-350 AMU/s, GC-MS interface temperature 250 ℃, ion source temperature 230 ℃, quadrupole rod temperature 150 ℃.
The detection results of the flavor substances of the fermented tea rice vermicelli by the bacillus coagulans PR06 are shown in table 6.
TABLE 6 detection results of flavor substances of Bacillus coagulans PR06 fermented tea Rice vermicelli
/>
The results in Table 6 show that the main flavors of the fermented tea rice vermicelli prepared by using Bacillus coagulans PR06 of the application are nonanal, trans-2-heptanal, decanal, geraniol, tridecanol, geranylacetone, 2, 4-di-tert-butylphenol, octyl salicylate, diisobutyl phthalate and the like.
In conclusion, the bacillus coagulans PR06 provided by the application has strong acid resistance and bile salt resistance, has resistance to most antibiotics, can be used for preparing common fermented rice vermicelli or common fermented rice noodles, and can also be used for preparing fermented tea rice vermicelli or fermented tea rice noodles which have no bitter taste and good steaming and sensory quality. In view of the fact that bacillus coagulans is one of the approved strains for common foods in China and belongs to the strains which are accepted in the industry and have high safety, the bacillus coagulans PR06 provided by the application has high practical application value.
The foregoing is only a few specific embodiments of the present application. The application is not limited to the above embodiments, but many variations are possible. All modifications directly derived or suggested to one skilled in the art from the present disclosure should be considered as being within the scope of the present application.
Claims (3)
1. A bacillus coagulans strain, characterized in that: the strain is classified and named as bacillus coagulansBacillus coagulans) PR06, which has been deposited at the China center for type culture Collection, under the accession number: cctccc NO: m20211589, the preservation address is: no. 299 is eight paths in Wuchang district of Wuhan, hubei province.
2. The use of bacillus coagulans according to claim 1 for the preparation of a common fermented rice vermicelli or a common fermented rice noodle product.
3. The use of bacillus coagulans according to claim 1 for the preparation of fermented tea rice vermicelli or fermented tea rice vermicelli products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310473617.4A CN116948865A (en) | 2023-04-28 | 2023-04-28 | Bacillus coagulans and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310473617.4A CN116948865A (en) | 2023-04-28 | 2023-04-28 | Bacillus coagulans and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116948865A true CN116948865A (en) | 2023-10-27 |
Family
ID=88446841
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310473617.4A Pending CN116948865A (en) | 2023-04-28 | 2023-04-28 | Bacillus coagulans and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116948865A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118086151A (en) * | 2024-04-23 | 2024-05-28 | 鄂尔多斯市蒙纯乳业有限责任公司 | Bacillus coagulans nj-1 and application thereof in fermented milk |
-
2023
- 2023-04-28 CN CN202310473617.4A patent/CN116948865A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118086151A (en) * | 2024-04-23 | 2024-05-28 | 鄂尔多斯市蒙纯乳业有限责任公司 | Bacillus coagulans nj-1 and application thereof in fermented milk |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020098097A1 (en) | Fermented lactobacillus plantarum and application thereof | |
US20230034193A1 (en) | Bifidobacterium animalis subsp. lactis i797, method for separation and purification thereof, and use thereof | |
EP2548948B1 (en) | Novel lactobacillus classified as lactobacillus plantarum, and use thereof | |
TWI241912B (en) | Novel Acid-and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol | |
CN108887663B (en) | Lactobacillus ferment product and preparation method thereof | |
KR20100128168A (en) | Novel bacterial strains having excellent production potential of conjugated linoleic acid | |
US11801276B2 (en) | Microorganism having ability to degrade ethanol and acetaldehyde, and composition and kit each including the same | |
CN116019185B (en) | Application of lactobacillus paracasei in preparation of fermented medlar | |
CN113403233B (en) | Application of multifunctional bacillus coagulans in preparation of probiotics nuts | |
Kadere et al. | Isolation and identification of lactic acid bacteria in Coconut Toddy (Mnazi) | |
KR102164198B1 (en) | Bifidobacterium longum subsp. infantis IN02 and Food composition comprising thereof | |
BORDIGNON et al. | Hydrolysis of isoflavones and consumption of oligosaccharides during lactic acid fermentation of soybean milk | |
KR20080102773A (en) | Novel plant-origin lactobacillus plantarum having activity for converting isoflavone into isoflavone aglycon and use thereof | |
EP2837292A1 (en) | Synbiotic food composition containing tagatose and probiotic lactic acid bacteria | |
CN114437960B (en) | Lactobacillus fermentum, microbial inoculum and preparation method thereof, application of lactobacillus fermentum and microbial inoculum, fermented food and preparation method of lactobacillus fermentum and microbial inoculum | |
CN116083312A (en) | Lactic acid bacteria capable of producing beta-glucosidase at high yield and application of lactic acid bacteria in fermented food | |
CN116948865A (en) | Bacillus coagulans and application thereof | |
KR101800174B1 (en) | Lactobacillus plantarum LRCC5308 strain having improved acid-resistance, method for enhancing acid-resistant stability, fruits and vegetables beverage containing the strain, and method for manufacturing thereof | |
US20230147942A1 (en) | Pharmaceutical composition comprising new lactobacillus plantarum kc3 strain and leonurus japonicus extract as active ingredients for preventing or treating respiratory disease and use thereof | |
KR101696670B1 (en) | Lactobacillus plantarum llp5193 having high resistance ability of acid and bile and high cell adhesion ability, and product comprising it as effective factor | |
KR20150075995A (en) | Leuconostoc mesenteroides DSR1310 Strain Having Excellent Acid and Salt Resistance and Use thereof | |
KR20150088588A (en) | Novel Gamma-Amino Butyric Acid Producing Strain of Lactobacillus Brevis CFM11 and Use of the Same | |
CN114350536B (en) | Lactobacillus plantarum, microbial inoculum and preparation method thereof, application of lactobacillus plantarum and microbial inoculum, fermented food and preparation method of fermented food | |
KR101871904B1 (en) | Leuconostoc mesenteroides YSM1219 and its use | |
KR102633113B1 (en) | Lactobacillus brevis Strain LRCC5229 suitable for functional fermented beverage and Use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |